Course Description: Psoriasis is a chronic life-ruining disease with significant unmet clinical need in the management of patients. It affects between 1%-3% of the population worldwide and is accompanied by substantial physical and psychosocial distress. Patients with moderate-to-severe plaque-type psoriasis often require lifelong therapy to control their disease. Traditional approaches such as PUVA, cyclosporine or methotrexate are problematic for long-term use because of inconvenience, organ toxicity, broadband immunosuppression, drug interactions and a loss of efficacy over time. Hence, there has been a demand for new therapeutic approaches that are more convenient, effective, safe, and immunologically selective. Numerous biological agents that modulate T cell and cytokine action at various steps along the pathogenic sequence have been developed and studied in clinical trials for the treatment of psoriasis.  Additionally, it is now becoming evident from recent published work that chronic inflammation has additional implications on organ systems other than the skin. Delegates will hear about the management of other common chronic inflammatory diseases and how these learnings can be applied to psoriasis.

Course Description: This course will introduce you to the patient’s perspective for the treatment and management of psoriasis. Patients want to be treated with a safe and effective therapy that provides a long term control of their psoriasis which will improve their quality of life. A patient focused treatment model can be an answer.

Course Description: Through the centuries, many remedies have been used for the treatment of psoriasis. Some were weird, some useless or harmful, others have survived until today and are still in use. This course will present the origin of most of the topical and systemic treatments. It will be emphasized that many of them have been discovered by serendipity rather than through specific research. The history of those treatments is quite interesting in consideration that they remained the same until 30 years ago.